Lek named the country's most reputable employer for the fifth time

  • Lek has been voted the most reputable employer in Slovenia once again, for the fourth time in a row and for the fifth time overall.
  • The Most Reputable Employer title is awarded by the employment  portal MojeDelo.com, which evaluates the reputation of Slovenian companies on the labor market.
  • Lek is creating a supportive and high-quality work environment  based on a strong culture of openness, cooperation and inclusion. 
18. 4. 2023

Lek has been awarded the prestigious Most Reputable Employer title for the fourth year in a row by the employment portal MojeDelo.com. According to the participants in the employer reputation survey, Lek earned the highest scores in five categories and emerged as the overall winner. 

According to Robert Ljoljo, President of the Board of Management of Lek and Sandoz Country President Slovenia, Lek's high reputation is the result of many years of building a strong and cohesive team and continuously improving the working environment: "I believe that every associate represents the company and builds on our reputation, so I would like to thank each and every one for contributing to making us the most reputable employer. At Lek, we have been committed to creating a supportive and high-quality work environment based on inclusion and diversity for many years. We are building a strong and inspiring culture of highly motivated associates, fostering innovation and continuously investing in employee development. We strive to create a working environment where associates can reach their full potential, which is regularly recognized  even outside the company."

One of Lek's core values is to nurture diversity, inclusion and equity, which are the foundation for creativity and the success of teams in tackling challenges. Our many practices ensure a work environment where associates – whatever their personal circumstances or potential limitations – are valued for their abilities and their contribution to our common goal.

In creating a modern work environment tailored to the needs of its associates, the most reputable employer prides itself on innovative ways of working, as well as digital P&O practices and tools. For years, the company has been supporting hybrid working and embracing an unbossed culture, giving it the agility it needs to grow in the challenging pharmaceutical market. With the recent announcement of a 400-million-dollar investment in a high-tech center for the production of biosimilars, the company plans to create 300 new jobs, further strengthening its position as one of the most important employers in Slovenia.

* * *

Novartis is the leading provider of medicines in Slovenia, where Lek d.d.,Novartis Pharma Services Inc. and Sandoz d.d., operate. Together we are building and maintaining the reputation of a dynamic, ethical, and trusted pharmaceutical company. Lek develops, manufactures, and markets effective, safe, and high quality medicines and active pharmaceutical ingredients. With our knowledge, quality, and experience we have gained an important role inNovartis' organizational structure, especially in the Novartis Operations,Global Drug Development and the generic division Sandoz. We are the leading Sandoz development center, and one of the key development sites for technologically complex projects. We invest a great deal in the development, education, and training of our employees. Novartis invested in Slovenia more thanEUR 3.4 billion since 2003.

About Sandoz
Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical needs. Our ambition is to be the world’s leading and most valued generics company. Our broad portfolio of high-quality medicines, covering major therapeutic areas, accounted for 2022 sales of USD 9.2 billion.

Novartis is reimagining medicine to improve and extend people’s lives. We deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. About 106,000 people of more than 140 nationalities work together to bring Novartis products to nearly 800million people around the world. Find out more at https://www.novartis.com

* * *

This press release contains statements and forecasts of future business operations. The forecasts include estimates based on all the information currently available to us. Should these forecasts prove unreliable, the actual results of business operations could be different from those expected.

- end -

Forfurther information, please contact:
Head Corporate Affairs
Lek Pharmaceuticals d.d.
Telephone: 01 580 22 43